News Focus
News Focus
icon url

DewDiligence

05/07/13 4:31 PM

#160834 RE: biocqr #160831

PTLA—Depending on the post-IPO valuation, I might be tempted. If the FXa reverser works well, I could see PFE (or BMY) buying the whole company. (An acquirer would shut down the betrixaban program, of course.)